Aizen Therapeutics advances Mirror Peptides as new drug class

Caltech AI professor and biotech veterans secure $13M in venture capital to create new category of biologic medicine SAN DIEGO, Nov. 21, 2024 /PRNewswire/ — Aizen Therapeutics, an AI-driven biotechnology company, today emerged from stealth with early-stage programs powered by its novel…